| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應商 |
| 156281-04-8 | 1H-Indole-3-ethanamine,N,N-dimethyl-5-(1-methylethyl)-; 5-ISO-PROPYL-N,N-DIMETHYLTRYPTAMINE |  | C15H22N2 | 詳情 | 供應商 | |
| 156257-97-5 | 1,6,7,8-Indolizinetetrol,octahydro-, tetraacetate (ester), [1S-(1a,6a,7b,8b,8ab)]- (9CI); 1,6,7,8-Indolizinetetrol, octahydro-, tetraacetate (ester), 1S-(1.alpha.,6.alpha.,7.beta.,8.beta.,8a.beta.)- |  | C16H23NO8 | 詳情 | 供應商 | |
| 156245-57-7 | 1H-Pyrrole-2-carboxaldehyde,4-(1,1-dimethylethyl)-; 4-tert-Butyl-1H-pyrrole-2-carboxaldehyde |  | C9H13NO | 詳情 | 供應商 | |
| 156245-29-3 | 1,3-Benzenedisulfonicacid, 4,5-dihydroxy-, potassium salt (1:2); 1,3-Benzenedisulfonicacid, 4,5-dihydroxy-, dipotassium salt (9CI) |  | C6H4K2O8S2 | 詳情 | 供應商 | |
| 112243-58-0 | 1H-Pyrido[4,3-b]indole,8-fluoro-2,3,4,5-tetrahydro-2-[3-(3-pyridinyl)propyl]-, hydrochloride (1:1); 1H-Pyrido[4,3-b]indole,8-fluoro-2,3,4,5-tetrahydro-2-[3-(3-pyridinyl)propyl]-, monohydrochloride(9CI); Gevotroline hydrochloride; WY 47384 |  | C19H21ClFN3 | 詳情 | 供應商 | |
| 156212-75-8 | 1-Propanamine,3-(cyclopentyldimethylsilyl)-; 1-Propanamine,3-(cyclopentyldimethylsilyl)-(9CI) |  | C10H23NSi | 詳情 | 供應商 | |
| 155242-98-1 | 1H-Benzimidazol-4-amine,1-methyl-; (1-Methyl-1H-benzimidazol-4-yl)amine; 4-Amino-1-methylbenzimidazole |  | C8H9N3 | 詳情 | 供應商 | |
| 155242-62-9 | 1H-Benzimidazole,6-methoxy-1-(methoxymethyl)-; 1H-Benzimidazole,6-methoxy-1-(methoxymethyl)-(9CI) |  | C10H12N2O2 | 詳情 | 供應商 | |
| 156206-15-4 | 1,6,7,8-Indolizinetetrol,octahydro-, 6-methanesulfonate, [1S-(1a,6b,7a,8b,8ab)]- (9CI); 1,6,7,8-Indolizinetetrol, octahydro-, 6-methanesulfonate, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |  | C9H17NO6S | 詳情 | 供應商 | |
| 138304-97-9 | 1,8-Naphthyridine-3-carboxamide,1,2-dihydro-4-hydroxy-N-(3-nitrophenyl)-2-oxo-1-phenyl-; 1,2-Dihydro-4-hydroxy-N-(3-nitrophenyl)-2-oxo-1-phenyl-1,8-naphthyridi ne-3-carboxamide |  | C21H14N4O5 | 詳情 | 供應商 | |
| 156206-09-6 | 1,6,7,8-Indolizinetetrol,octahydro-6-methyl-, [1S-(1a,6a,7a,8b,8ab)]- (9CI); 1,6,7,8-Indolizinetetrol, octahydro-6-methyl-, 1S-(1.alpha.,6.alpha.,7.alpha.,8.beta.,8a.beta.)- |  | C9H17NO4 | 詳情 | 供應商 | |
| 156206-08-5 | 1,6,7,8-Indolizinetetrol,6-ethenyloctahydro-, [1S-(1a,6a,7a,8b,8ab)]- (9CI); 1,6,7,8-Indolizinetetrol, 6-ethenyloctahydro-, [1S-(1alpha,6alpha,7alpha,8b閠a,8ab閠a)]- (9CI); 1,6,7,8-Indolizinetetrol, 6-ethenyloctahydro-, 1S-(1.alpha.,6.alpha.,7.alpha.,8.beta.,8a.beta.)-; 1,6,7,8-Indolizinetetrol,6-ethenyloctahydro-,[1S-(1alpha,6alpha,7alpha,8bta,8abta)]-(9CI) |  | C10H17NO4 | 詳情 | 供應商 | |
| 156206-05-2 | 1,7,8-Indolizinetriol,6-butoxyoctahydro-, [1S-(1a,6b,7a,8b,8ab)]- (9CI); 1,7,8-Indolizinetriol, 6-butoxyoctahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |  | C12H23NO4 | 詳情 | 供應商 | |
| 156206-03-0 | 1,7,8-Indolizinetriol,6-(diethylamino)octahydro-, [1S-(1a,6b,7a,8b,8ab)]- (9CI); 1,7,8-Indolizinetriol, 6-(diethylamino)octahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |  | C12H24N2O3 | 詳情 | 供應商 | |
| 156206-02-9 | 1,7,8-Indolizinetriol,6-(butylethylamino)octahydro-, [1S-(1a,6b,7a,8b,8ab)]- (9CI); 1,7,8-Indolizinetriol, 6-(butylethylamino)octahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |  | C14H28N2O3 | 詳情 | 供應商 | |
| 156206-01-8 | 1,7,8-Indolizinetriol,6-[bis(2-hydroxyethyl)amino]octahydro-, [1S-(1a,6b,7a,8b,8ab)]- (9CI); 1,7,8-Indolizinetriol, 6-bis(2-hydroxyethyl)aminooctahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |  | C12H24N2O5 | 詳情 | 供應商 | |
| 156205-87-7 | 1,7,8-Indolizinetriol,6-(diethylamino)octahydro-, triacetate (ester), [1S-(1a,6b,7a,8b,8ab)]- (9CI); 1,7,8-Indolizinetriol, 6-(diethylamino)octahydro-, triacetate (ester), 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |  | C18H30N2O6 | 詳情 | 供應商 | |
| 156205-86-6 | 1H-Pyrrolizine-1,2,7-triol,hexahydro-3-[[(phenylmethyl)amino]methyl]-, [1R-(1a,2b,3a,7b,7aa)]- (9CI); 1H-Pyrrolizine-1,2,7-triol, hexahydro-3-(phenylmethyl)aminomethyl-, 1R-(1.alpha.,2.beta.,3.alpha.,7.beta.,7a.alpha.)- |  | C15H22N2O3 | 詳情 | 供應商 | |
| 156205-85-5 | 1,7,8-Indolizinetriol,octahydro-6-[(phenylmethyl)amino]-, [1S-(1a,6b,7a,8b,8ab)]- (9CI); 1,7,8-Indolizinetriol, octahydro-6-(phenylmethyl)amino-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |  | C15H22N2O3 | 詳情 | 供應商 | |
| 156205-83-3 | 1,7,8-Indolizinetriol,octahydro-6-[(2-methoxyethyl)amino]-, [1S-(1a,6b,7a,8b,8ab)]- (9CI); 1,7,8-Indolizinetriol, octahydro-6-(2-methoxyethyl)amino-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |  | C11H22N2O4 | 詳情 | 供應商 | |